Leaderboard

En | De
Sie sind hier: Gastroenterologie » Oesophagus » Neoplasie 28. Juli 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Magen-Darm
Oesophagus
Motilitätsstörungen
Neoplasie
Anderes
Pankreas
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 1969  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 39363  
   
DNA methylation profiling enables subclassification of mucinous ovarian carcinoma and distinguishes it from extraovarian mucinous metastases.
Cell Rep Med
Calina TG, Grafenhorst E, Schallenberg S, Möbs M, Daenekas B, Sabo AA, Chen B, Koch I, Janik T, Churchman M, Gourley C, Christie EL, Vasilescu C, Herlea V, Schmitt WD, Leopold N, Heitz F, Vlaski A, Tolkach Y, Bremmer F, Klauschen F, Büttner R, Ströbel P, Burandt E, Sauter G, Heppner FL, Taube ET, Sehouli J, Braicu IE, Euskirchen P, Horst D, Gorringe KL, Capper D, Dragomir MP.
PMID: 42508406 [PubMed - as supplied by publisher]


Surveillance vs Standard Surgery and Cost-Effectiveness After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Secondary Analysis of a Randomized Clinical Trial.
JAMA Netw Open
Gangaram Panday SSG, van Klaveren D, Lagarde SM, van der Wilk BJ, Eyck BM, Rosman C, Noordman BJ, Valkema MJ, Bisseling TM, Coene PLO, Dekker JWT, van Det MJ, van Dieren JM, Doukas M, van Esser S, Fiets WE, Hartgrink HH, Heisterkamp J, Hol L, Klarenbeek B, Kouw E, Kouwenhoven EA, Luyer MD, Mostert B, Nieuwenhuijzen GAP, Oostenbrug LE, Oude Voshaar M, Pierie JP, van Sandick JW, Sosef MN, Spaander MCW, Steyerberg EW, Valkema R, van der Zaag ES, van Lanschot JJB, Lingsma HF, Wijnhoven BPL, Surgery as Needed for Oesophageal Cancer (SANO) Study Group.
PMID: 42507446 [PubMed - indexed for MEDLINE]


Comparison of induction chemotherapy followed by concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by surgery and (chemo)radiotherapy in locoregionally advanced hypopharyngeal carcinoma: a prospective cohort study.
Clin Transl Oncol
Zhao DW, Li SR, Yang F, Guo XF, Sun XZ, Li L, Tan SC, Qin JY, Qu YJ, Wang ZQ, Ma L, Wang PG.
PMID: 42507334 [PubMed - as supplied by publisher]


Adaptive 3D-CRT with CCRT for head and neck cancer: resource limited single center experience in Bangladesh.
Radiol Phys Technol
Al-Amin, Das PK, Saha SK, Mannan A, Tania AB, Alim S, Poddar P, Hasnat A, Islam R.
PMID: 42507086 [PubMed - as supplied by publisher]


Colon interposition after esophagectomy: a 15-year single-center experience.
Langenbecks Arch Surg
Kemeter M, Thumfart L, Heger P, Hüttner FJ, Diener MK, Giulini L, Dubecz A.
PMID: 42507071 [PubMed - indexed for MEDLINE]


A Weighted Neural Network Model Based on Laboratory Tests for Identifying Lymph Node Metastases in Esophageal Squamous Cell Carcinomas.
Biosensors (Basel)
Ouyang Q, Gao Z, Yang J, Wang S, Li Z, Zhang Y, Chen T, Xu X, Han R, Chen H.
PMID: 42505453 [PubMed - indexed for MEDLINE]


Efficacy analysis of first-line chemoimmunotherapy with or without radiotherapy in stage IVB esophageal squamous cell carcinoma: a real-world study.
Future Oncol
Zhang Y, Jin Y, Zhang R, Zhao J, Li B.
PMID: 42504461 [PubMed - as supplied by publisher]


Integrating habitat-based radiomics, 3D deep learning, and clinical variables for detection of early-stage esophageal squamous cell carcinoma on noncontrast chest CT: A multicenter study.
Eur J Radiol
Ye C, Song D, Xu J, Li S, Sun H, Liu J, Wen C, Cao G.
PMID: 42501614 [PubMed - as supplied by publisher]


Risk of cancer in periodontal disease: an umbrella review of meta-analyses.
Front Immunol
Yuan J, Wang S, Xia S, Lou S, Yang H, Wei J, Chen Y, Yu L, Du Y, Yu L, Sun L, Wang S.
PMID: 42500648 [PubMed - indexed for MEDLINE]


Comparison of the diagnostic value of white light endoscopic, narrow band imaging, and iodine staining individually and in combination for early esophageal cancer and precancerous lesions.
Front Oncol
Yin X, Meng M.
PMID: 42500285 [PubMed]


Performance of DeepSeek V3 and ChatGPT-4o in answering esophageal cancer-related questions.
Medicine (Baltimore)
Yang Q, Yi J, Gong A, Li Y, Feng Q, Fu A, Li J, Zhan Y.
PMID: 42499121 [PubMed - indexed for MEDLINE]


Essential Updates 2024-2025: Surgical Strategy for Esophageal Cancer Toward a New Paradigm in the Era of Immunotherapy and Personalization.
Ann Gastroenterol Surg
Oya S, Yagi K, Baba Y.
PMID: 42495683 [PubMed - as supplied by publisher]


Systematic Review and Meta-Analysis on the Efficacy and Safety of Salvage Esophagectomy for T4 Esophageal Squamous Cell Carcinoma.
Ann Gastroenterol Surg
Sakai M, Kuriyama K, Nagai K, Shirabe K, Saeki H.
PMID: 42495669 [PubMed - as supplied by publisher]


Efficacy and safety of neoadjuvant chemotherapy with immunotherapy versus chemotherapy alone in esophageal squamous cell carcinoma: a meta-analysis based on randomized controlled trials.
Front Immunol
Ye Y, Zhang L, Yang Z, Huang Y, Chen M, Zhang S, Zeng T, Chen C, Zheng B.
PMID: 42495613 [PubMed - indexed for MEDLINE]


Circular RNAs in esophageal squamous cell carcinoma: What do we know so far?
iScience
Yang M, Ye J, Xiong J, Chen Y, Zhao Y, Wang Z, Xu S, Wang J.
PMID: 42495543 [PubMed]


Long-term outcomes of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer: a prospective phase II study.
Front Oncol
Jingu K, Umezawa R, Yamamoto T, Takahashi N, Suzuki Y, Kishida K, Omata S, Harada H, Takahashi M, Kamei T, Matsushita H.
PMID: 42494587 [PubMed]


Does adding immunotherapy to neoadjuvant chemotherapy increase postoperative morbidity in gastroesophageal junction adenocarcinoma? A propensity score-matched study.
Front Immunol
Zhang H, Huang Q, Du J, Wan X.
PMID: 42490951 [PubMed - indexed for MEDLINE]


A Simplified Nomogram for Primary Population-Based Screening of Esophageal Cancer: An Internally Validated Shandong Cohort Study Addressing Data Imbalance.
Risk Manag Healthc Policy
Hou J, He X, Gao F, Ren T, Ren L, Wang X.
PMID: 42488795 [PubMed]


Targeting notch signaling pathway in esophageal cancer: from molecular insights to therapies.
Oncol Rev
Bhattacharyya S, Ghosh H, Hamza A, Biersack B, Gan GN, Sharma P, Dandawate P.
PMID: 42488503 [PubMed]


Additional chemoradiotherapy versus esophagectomy for early esophageal cancer: an integrated analysis of reconstructed time-to-event data.
Ther Adv Gastroenterol
Huang PF, Chen YG, Lu MC, Yang CW.
PMID: 42488030 [PubMed]


   
   Artikel 1 - 20 / 39363    Seite 1 von 1969  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1